Tumor No More: How Humanity Can Get Rid of Cancer

Imagine a world – not that far into the future – where a vaccine could prevent the loss of the 10 million lives that are taken by cancer annually.  Does it sound like an impossibility? Well, we might be closer than you think! 

Building on the momentum and knowledge of the use of mRNA technologies in vaccine development during the COVID-19 Pandemic, mRNA technology is posed to become a promising opponent to finally end humanity’s battle against cancer. Aligned with the exciting developments in the area of therapeutic cancer vaccines, FII Institute has just released the “Cancer Vaccine Fairness: Tumor No More” Report, which examines the potential impact, challenges, and a way forward to develop these vaccines through the best and most equitable practices to put an end to cancer.

“Defeating cancer with therapeutic vaccines is a challenge for humanity. At FII Institute, making an Impact on Humanity is at the core of what we do, so we want to take on that challenge as equitably and efficiently as possible. In this report, we have made a proposal for how these ambitious goals can be achieved. We see it as a step towards a world where health means wealth– and not the other way around,” said Richard Attias, CEO of FII Institute in the report’s editorial.

Attias added, “This is one of the best examples of the positive impact that new technologies can have on humanity, and in this report, we tried to find out how the mRNA success story might continue.”

While mRNA technology promises to defeat cancer by utilizing individual, customized vaccines for each patient, a variety of challenges still lie ahead – from equality of access to the complicated supply chain process. Cancer therapy research takes time, and dozens of mRNA cancer vaccine studies are still ongoing around the world, but current advancements have brought the healthcare sector to plan for the future of therapy for specific cancers through developing roadmaps.

Now is exactly the right time to begin the debate about the best and most equitable way to put an end to cancer.  The report suggests that as speed was important for fighting Covid-19, it will be just as important for fighting cancer.

The report speculates that once the healthcare industry identifies the structure to be targeted, the effort required to produce a specific mRNA therapy for that target is relatively simple. Still, there are bottlenecks that remain, including accessibility, competition, and the importance of support from local decision-makers.

Illustrated by Daniel Hertzberg, an award-winning illustrator and graphic designer whose illustrations for scientific topics are published by top international media outlets, the report will be of interest to those keen to learn more about cancer therapies, those in the healthcare industry, or anyone who has lost a loved one to cancer and can be read here.

#cancer #vaccines #vaccine #healthcare #health #organization #international #mrna #mrnavaccines #covid #infection #disease #tumor #technology

Public Investment Fund (PIF)Ministry of Investment aramco BNY Mellon الصندوق الثقافي Cultural Development Fund Diriyah Gate Development Authority EmaarHSBC Maaden وجهة مسار | Masar Destination Reliance Industries Limited ROSHN l روشن The Royal Commission for AlUla SABIC Sanabil Investments SNB Capital stcSoftBank Group Corp. Standard Chartered Bank Red Sea Global TONOMUS